Sudafed, Tylenol, DayQuil, NyQuil and Store Brand Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
DayQuil Cough Medicine
Case Name (Date)
Diesel et al. v. The Procter & Gamble Co.
22-cv-892, E.D. Mo.
(July 2022)
Meza et al. v. The Procter & Gamble Co.
23-cv-241, S.D. Ohio
(Jan. 2023)
Product/Service
DayQuil cough medicine
Allegations
Falsely marketing medicine as “non-drowsy” when an ingredient (dextromethorphan hydrobromide, or DXM) causes drowsiness
Status
Pending
Class-Action Tracker
DayQuil Super C
Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…
DayQuil Medicines with DXM
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
The Latest
How Investing in the Cutting Edge Can Bleed You Dry
What consumers should know about software tethering.
Crest ‘Recycle Ready’ Toothpaste Tubes
The bottom line? Toothpaste tubes aren’t generally getting recycled.
2023 Reasonable Consumer Quiz
See how you stack up.
By the Numbers: Greenwashing Class-Action Lawsuits
TINA.org has tracked more than 150 lawsuits alleging greenwashing.
CATrends: OTC Cold and Flu Meds Falsely Marketed as Nasal Decongestants
An FDA panel’s recent findings has led to a flood of lawsuits.